IT8419675A0 - Antagonisti ricettori di adenosina - Google Patents
Antagonisti ricettori di adenosinaInfo
- Publication number
- IT8419675A0 IT8419675A0 IT8419675A IT1967584A IT8419675A0 IT 8419675 A0 IT8419675 A0 IT 8419675A0 IT 8419675 A IT8419675 A IT 8419675A IT 1967584 A IT1967584 A IT 1967584A IT 8419675 A0 IT8419675 A0 IT 8419675A0
- Authority
- IT
- Italy
- Prior art keywords
- receptor antagonists
- adenosine receptor
- adenosine
- antagonists
- receptor
- Prior art date
Links
- 229940121359 adenosine receptor antagonist Drugs 0.000 title 1
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/467,894 US4593095A (en) | 1983-02-18 | 1983-02-18 | Xanthine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8419675A0 true IT8419675A0 (it) | 1984-02-17 |
IT1196031B IT1196031B (it) | 1988-11-10 |
Family
ID=23857582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT19675/84A IT1196031B (it) | 1983-02-18 | 1984-02-17 | Antagonisti ricettori di adenosina |
Country Status (10)
Country | Link |
---|---|
US (1) | US4593095A (it) |
JP (1) | JPS59205377A (it) |
BE (1) | BE898946A (it) |
CA (1) | CA1234804A (it) |
DE (1) | DE3406275A1 (it) |
FR (1) | FR2541281B1 (it) |
GB (2) | GB8403574D0 (it) |
IT (1) | IT1196031B (it) |
NL (1) | NL8400514A (it) |
SE (1) | SE456680B (it) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769377A (en) * | 1983-02-18 | 1988-09-06 | The Johns Hopkins University | Adenosine receptor antagonists |
US4696932A (en) * | 1984-10-26 | 1987-09-29 | The United States Of America As Represented By The Department Of Health And Human Services | Biologically-active xanthine derivatives |
GB8510758D0 (en) * | 1985-04-27 | 1985-06-05 | Wellcome Found | Compounds |
US5017577A (en) * | 1986-04-25 | 1991-05-21 | Burroughs Wellcome Co. | Methods for treating viral infection |
US4772607A (en) * | 1986-05-20 | 1988-09-20 | Warner-Lambert Company | Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
US4755517A (en) * | 1986-07-31 | 1988-07-05 | Warner-Lambert Company | Derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
JPS63154687A (ja) * | 1986-11-13 | 1988-06-27 | マリオン・ラボラトリーズ・インコーポレーテッド | 8ーアリールキサンチン |
US4783530A (en) * | 1986-11-13 | 1988-11-08 | Marion Laboratories, Inc. | 8-arylxanthines |
US5015647A (en) * | 1987-04-24 | 1991-05-14 | Burroughs Wellcome Co. | Method for treating viral infections |
US5032593A (en) * | 1988-07-01 | 1991-07-16 | Marion Merrell Dow Inc. | Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines |
US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
DE8817122U1 (it) * | 1988-12-22 | 1993-02-04 | Boehringer Ingelheim Kg, 6507 Ingelheim, De | |
GB8906792D0 (en) | 1989-03-23 | 1989-05-10 | Beecham Wuelfing Gmbh & Co Kg | Treatment and compounds |
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
NZ240644A (en) * | 1990-11-21 | 1994-08-26 | Smithkline Beecham Corp | Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf) |
US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
TW252044B (it) * | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
US5877179A (en) * | 1992-09-29 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells |
WO1994025462A1 (en) * | 1993-05-03 | 1994-11-10 | The United States Of America, Represented By The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
US5504090A (en) * | 1994-03-30 | 1996-04-02 | Trustees Of The University Of Pennsylvania | Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury |
GB9415529D0 (en) | 1994-08-01 | 1994-09-21 | Wellcome Found | Phenyl xanthine derivatives |
US6323201B1 (en) | 1994-12-29 | 2001-11-27 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
US6930101B1 (en) * | 1999-05-17 | 2005-08-16 | The Regents Of The University Of California | Thiazolopyrimidines useful as TNFα inhibitors |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
ES2166270B1 (es) * | 1999-07-27 | 2003-04-01 | Almirall Prodesfarma Sa | Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona. |
US6815446B1 (en) | 1999-08-31 | 2004-11-09 | Vanderbilt University | Selective antagonists of A2B adenosine receptors |
ATE319452T1 (de) * | 1999-10-29 | 2006-03-15 | Kyowa Hakko Kogyo Kk | Arzneimittel gegen essstörungen |
AU2001238665A1 (en) | 2000-02-23 | 2001-09-03 | Cv Therapeutics, Inc. | Method of identifying partial agonists of the a2a receptor |
US20080318983A1 (en) * | 2001-11-09 | 2008-12-25 | Rao Kalla | A2b adenosine receptor antagonists |
AU2002359365B2 (en) | 2001-11-09 | 2008-07-10 | Gilead Sciences, Inc. | A2B adenosine receptor antagonists |
US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US7125993B2 (en) * | 2001-11-09 | 2006-10-24 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US7317017B2 (en) * | 2002-11-08 | 2008-01-08 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US7205403B2 (en) * | 2002-02-01 | 2007-04-17 | King Pharmaceuticals Research And Development, Inc. | 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
EP1524984A1 (en) * | 2002-07-29 | 2005-04-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging using a2a receptor agonists |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
RU2385322C2 (ru) * | 2004-09-01 | 2010-03-27 | Си Ви Терапьютикс, Инк. | Способ заживления ран с применением антагонистов аденозинового рецептора a2b |
KR20070083714A (ko) | 2004-10-20 | 2007-08-24 | 씨브이 쎄러퓨틱스, 인코포레이티드 | A2a 아데노신 수용체 작용제의 용도 |
PL1989214T3 (pl) | 2006-02-03 | 2017-07-31 | Gilead Sciences, Inc. | Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów |
WO2008028140A1 (en) * | 2006-09-01 | 2008-03-06 | Cv Therapeutics, Inc. | Methods and compositions for increasing patient tolerability during myocardial imaging methods |
US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
JP2011502101A (ja) * | 2006-09-29 | 2011-01-20 | ギリアード・パロ・アルト・インコーポレイテッド | 肺疾患の病歴を有する患者における心筋画像化法 |
JP2010515081A (ja) * | 2007-01-03 | 2010-05-06 | ギリアード・パロ・アルト・インコーポレイテッド | 心筋灌流画像化 |
JP2012504147A (ja) * | 2008-09-29 | 2012-02-16 | ギリアード サイエンシーズ, インコーポレイテッド | 多検出器型コンピュータ断層撮影法において使用するための心拍数コントロール薬およびA−2−α受容体作動薬の組み合わせ |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2840559A (en) * | 1954-06-22 | 1958-06-24 | Krantz Jr | Nuclearly substituted 8-theophyllines and method of making the same |
DE1091570B (de) * | 1958-10-23 | 1960-10-27 | Albert Ag Chem Werke | Verfahren zur Herstellung von in 8-Stellung substituierten 1, 3-Dialkylxanthinen |
GB982079A (en) * | 1962-05-01 | 1965-02-03 | Dresden Arzneimittel | Process for the production of xanthine derivatives |
BE636699A (it) * | 1962-08-31 | |||
EP0011399A1 (en) * | 1978-11-11 | 1980-05-28 | FISONS plc | N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them |
US4452788A (en) * | 1982-04-21 | 1984-06-05 | Warner-Lambert Company | Substituted 8-phenylxanthines |
-
1983
- 1983-02-18 US US06/467,894 patent/US4593095A/en not_active Expired - Fee Related
-
1984
- 1984-02-10 GB GB848403574A patent/GB8403574D0/en active Pending
- 1984-02-14 SE SE8400788A patent/SE456680B/sv not_active IP Right Cessation
- 1984-02-17 GB GB08404243A patent/GB2135311B/en not_active Expired
- 1984-02-17 NL NL8400514A patent/NL8400514A/nl not_active Application Discontinuation
- 1984-02-17 FR FR8402472A patent/FR2541281B1/fr not_active Expired
- 1984-02-17 IT IT19675/84A patent/IT1196031B/it active
- 1984-02-17 BE BE0/212418A patent/BE898946A/fr not_active IP Right Cessation
- 1984-02-17 CA CA000447705A patent/CA1234804A/en not_active Expired
- 1984-02-17 DE DE19843406275 patent/DE3406275A1/de not_active Ceased
- 1984-02-18 JP JP59028010A patent/JPS59205377A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1234804A (en) | 1988-04-05 |
GB8404243D0 (en) | 1984-03-21 |
US4593095A (en) | 1986-06-03 |
SE8400788D0 (sv) | 1984-02-14 |
IT1196031B (it) | 1988-11-10 |
FR2541281B1 (fr) | 1988-01-29 |
BE898946A (fr) | 1984-06-18 |
GB2135311A (en) | 1984-08-30 |
SE456680B (sv) | 1988-10-24 |
JPS59205377A (ja) | 1984-11-20 |
DE3406275A1 (de) | 1984-09-27 |
GB2135311B (en) | 1986-11-05 |
NL8400514A (nl) | 1984-09-17 |
SE8400788L (sv) | 1984-08-19 |
FR2541281A1 (fr) | 1984-08-24 |
GB8403574D0 (en) | 1984-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1196031B (it) | Antagonisti ricettori di adenosina | |
IT1176716B (it) | Dispositivo di trivella | |
DK529484D0 (da) | Substituerede 1-amino-4-nitro-acridinoner | |
DK166884D0 (da) | Pyrimidinderivater | |
FR2540117B1 (fr) | Vinylcephalosporines substituees | |
DK530888D0 (da) | Leukotrien -ltd4- og - ltb4-antagonister | |
DK309084A (da) | Aminopyrimidinderivater | |
DE3482685D1 (de) | Leukotrien-antagonisten. | |
ATE156130T1 (de) | Selektive adenosinreceptoren | |
DK198784D0 (da) | Pyrimidonderivater | |
DK164884D0 (da) | Syldkonstruktion | |
DK130984D0 (da) | Leukotrien-antagonister | |
DK292184A (da) | Saamaskine | |
DK510484D0 (da) | Substituerede pyrimidiner | |
BR8401519A (pt) | Estrutura de assento | |
FI834026A0 (fi) | Adapter foer en elektrisk stroemskena | |
DK21085A (da) | Leukotrienantagonister | |
KR840004265U (ko) | 타일 | |
KR850001103U (ko) | 평 식 기 | |
DE3468880D1 (de) | Substituted triazanonane | |
DK210884A (da) | Saamaskine | |
SE8302063D0 (sv) | Syrafast golvmassa | |
NO833887L (no) | Gulvkonstruksjon | |
BR6401795U (pt) | Receptor dedicado | |
BR6301093U (pt) | Azulejo |